Healio

Higher-dose insulin glargine safe, effective among children with type 1 diabetes

Children and adolescents with type 1 diabetes assigned insulin glargine injection 300 U/mL for 26 weeks experienced a reduction in HbA1c similar to that of children assigned insulin glargine 100 U/mL, ...
Healio

FDA OKs higher dose insulin glargine for kids, plus more top stories in endocrinology

The top stories in endocrinology last week included the FDA’s approval of a higher dose insulin glargine for children with diabetes, along with new data that suggest the readmission rate after ...
FiercePharma

Patients Continuing On Sanofi's Lantus® Had Lower Blood Sugar Levels Than Those who Switched to Insulin Detemir

Real World Outcome Study of Patients with Type 2 Diabetes Presented at American Diabetes Association 74th Scientific Sessions BRIDGEWATER, N.J., June 14, 2014 /PRNewswire/ -- Sanofi US announced today ...
Nature

How do detemir and glargine compare when added to oral agents in insulin-naïve patients with type 2 diabetes mellitus?

Arising from: Marks JB (2008) How do detemir and glargine compare when added to oral agents in insulin-naïve patients with type 2 diabetes mellitus? Nat Clin Pract ...
Healthline

Dosage Details for Toujeo

If you have diabetes, your doctor may suggest Toujeo (insulin glargine) as a treatment option. This article describes the dosages of Toujeo, as well as its form, strength, and how to take it. It’s ...
FiercePharma

SANOFI'S NEW BASAL INSULIN LANTUS XR, KNOWN AS TOUJEO IN THE U.S. AND EUROPE, APPROVED IN JAPAN FOR THE TREATMENT OF DIABETES MELLITUS

SANOFI'S NEW BASAL INSULIN LANTUS XR, KNOWN AS TOUJEO IN THE U.S. AND EUROPE, APPROVED IN JAPAN FOR THE TREATMENT OF DIABETES MELLITUS Paris, France - July 3, 2015 - Sanofi announced today that the ...